Earnings Preview: Will Oracle Live Up to Cautious Optimism?

By Chris Lange Published Jun 9, 11:15AM EDT

Follow 24/7 Wall St. on Google

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Earnings Preview: Will Oracle Live Up to Cautious Optimism? — © Scott Olson / Getty Images

Oracle Corp. (NYSE: ORCL | ORCL Price Prediction) is scheduled to report its fiscal fourth-quarter financial results on Monday. Analysts expect to see $1.58 in earnings per share (EPS) on $13.73 billion in revenue. That earnings estimate is the same as 60 days ago. The same period of last year had EPS of $1.54 and $11.84 billion in revenue. The company posted modest earnings surprises in the prior two quarters.

Over the past 52 weeks, the stock is up roughly 48%. However, it is up only closer to 31.5% year to date.

Despite a strong run, this top software stock is still offering a good entry point. Oracle develops, manufactures, markets, sells, hosts and supports database and middleware software, application software, cloud infrastructure, hardware systems and related services worldwide.

The company licenses its Oracle Database software to customers, which is designed to enable reliable and secure storage, retrieval and manipulation of various forms of data. Its Oracle Fusion Middleware software aims to build, deploy, secure, access and integrate business applications, as well as automate their business processes.
[nativounit]
Last year, Oracle and Cerner closed an agreement for the former to acquire the latter through an all-cash tender offer for $95 per share, or approximately $28.3 billion in equity value. Cerner is a leading provider of digital information systems used within hospitals and health systems to enable medical professionals to deliver better health care to individual patients and communities.

[wallst_email_signup]

A few analysts recently came out in favor of the stock:

Barclays maintained a Buy rating and raised its price target to $113 from $85 on June 7.
Jefferies maintained a Buy rating and raised its $105 price target to $125 on June 5.
KeyCorp maintained an Overweight rating and raised its $98 price target to $105 on April 20.
UBS maintained a Neutral rating but raised its price target to $90 from $87 on March 24.

[recirclink id=1255873]

The company currently offers a dividend of roughly 1.5%, or $1.60. It has a market cap of $290.2 billion.

Friday morning, shares of Oracle were trading up 2% at $109.67, in a 52-week range of $60.78 to $110.14. The consensus price target is $100.62, which implies downside of 6.4% from the most recent closing price of $107.48.

About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.